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mediated locomotor recovery after spinal
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Locomotor function, mediated by lumbar neural circuitry, is modulated by descending spinal
pathways. Spinal cord injury (SCI) interrupts descending projections and denervates lumbar
motor neurons (MNs). We previously reported that retrogradely transported neurotrophin-3
(NT-3) to lumbar MNs attenuated SCI-induced lumbar MN dendritic atrophy and enabled
functional recovery after a rostral thoracic contusion. Here we functionally dissected the role
of descending neural pathways in response to NT-3-mediated recovery after a T9 contusive
SCI in mice. We find that residual projections to lumbar MNs are required to produce leg
movements after SCI. Next, we show that the spared descending propriospinal pathway,
rather than other pathways (including the corticospinal, rubrospinal, serotonergic, and
dopaminergic pathways), accounts for NT-3-enhanced recovery. Lastly, we show that NT-3
induced propriospino-MN circuit reorganization after the T9 contusion via promotion of
dendritic regrowth rather than prevention of dendritic atrophy.
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Locomotion is a universal and robust motor function thatallows humans and other animals to interact with theirsurroundings1. Although locomotion appears to be rhythmic
and repetitive, it is a complex motor behavior that involves spinal
circuits at caudal regions and descending pathways from rostral
centers2. In the spinal cord, motoneurons (MNs) are the final
stage of neural processing for the execution of locomotor
behaviors3,4. In the supraspinal areas, pathways from the cortex
and brainstem contribute to the planning and initiation of
locomotion1,5. The recruitment of both spinal and supraspinal
motor circuits collectively produce and adapt the rhythms and
patterns of locomotion with behavioral needs in immediate
surroundings6.
Spinal cord injury (SCI) not only disrupts descending pathways
at the injury site but also results in MN degeneration with den-
dritic withdrawal or atrophy below the injury, collectively leading
to impaired locomotor functions7,8. Clinically, ~67% of SCI
patients are subject to an incomplete injury9. Imaging10, elec-
trophysiological11, and anatomical evaluations12,13 reveal that
SCIs, even in the most severe cases, usually spare some region of
the spinal cord. These spared neural tissues contain residual fibers
from mixed supraspinal and propriospinal pathways that main-
tain a physical connection with the lumbar motor circuits which
coordinate locomotion14,15. Therefore, the residual connections
play important roles in facilitating locomotor recovery after SCI.
For example, Leonie and colleagues showed that neuromodula-
tion of residual reticulospinal projections after severe spinal cord
contusion relayed the cortical command and enabled functional
locomotor recovery14.
In addition to supraspinal pathways, the propriospinal system
is often partially intact following contusive SCI. Reorganization of
propriospinal relay connections that bypass the injury sites are
able to mediate spontaneous locomotor recovery15–17. Besides
residual projections, studies have shown that neurotherapy and
rehabilitation can change the phenotype of MNs and increase
MN plasticity, leading to remodeling of lumbar motor circuits
that control locomotor behaviors after SCI8,18,19. Thus, residual
projections and lumbar MNs are two potential targets for ther-
apeutic interventions that could enable locomotor recovery
after SCI.
Neurotrophin-3 (NT-3), a member of the neurotrophic family
of proteins, has been shown to play both growth-stimulating and
chemo-attractive roles in motor restoration by promoting axonal
growth and synaptic plasticity in multiple spinal pathways20,21.
We recently reported that retrogradely transported NT-3 to the
lumbar MNs significantly attenuated SCI-induced lumbar MN
dendritic atrophy and improved locomotor recovery in adult mice
after a moderate T9 contusive SCI7. However, the mechanism
underlying recovery remains elusive. Is the extent of NT-3-
induced recovery related to the preservation of lumbar MN
dendrites or the degree of spared and/or sprouted descending
pathways, or both? Moreover, if residual projections are involved,
which descending pathways survive a contusion injury, respond
to NT-3 treatment, and contribute to the reorganization of the
lumbar neural circuit and thus to the recovery of locomotor
function? Addressing these questions has considerable ther-
apeutic implications for developing care and treatment of SCI.
In this study, we first demonstrate that residual descending
pathways projecting to the lumbar region of spinal cord are
essential for hindlimb locomotion restoration. We then show that
a moderate thoracic contusion at T9 abolishes the corticospinal
tract (CST) and rubrospinal tract (RST) projections down to the
spinal cord, but retains partial neural transmissions downstream,
which can be reinforced by the NT-3 therapy through residual
descending propriospinal neurons (dPNs) and their tract (dPST).
With anatomical and physiological analysis and pathway-selective
silencing, we also reveal that the spared propriospinal pathway,
rather than other descending pathways, is functionally associated
with NT-3-mediated locomotor recovery after SCI. Quantitative
analysis of time-dependent dendritic ramifications of lumbar
MNs suggests that NT-3 mediates MN recovery via promoting
dendritic regrowth (a neuroplasticity mechanism) rather than by
preventing dendritic atrophy (a neuroprotective mechanism).
Results
Descending pathways are required in NT-3 mediated recovery.
Our previous results demonstrated that retrograde transport of
adeno-associated virus-NT-3 (AAV-NT-3) to lumbar MNs par-
tially restored lumbar motor circuitry, including both lumbar
MNs and surrounding residual descending fibers, leading to
enhanced locomotor recovery after T9 contusion7. However, it
remains unclear whether lumbar MNs and spared descending
pathways work alone or together to induce NT-3-mediated
recovery. To investigate the involvement of descending pathways,
we first conducted a complete spinal transection at T9 spinal cord
and injected either adeno-associated virus–green fluorescent
protein (AAV-GFP) or a mixture of AAV-GFP and AAV-NT-3
(1:1 ratio) through the pre-demyelinated sciatic nerves for ret-
rograde transport of GFP or NT-3 to lumbar MNs (Fig. 1a). Six
weeks post-injury (wpi), we found that the T9 transection created
a complete lesion gap (GFAP-negative) in the spinal cord that
severed all descending projections, including the biotinylated
dextran amine (BDA)-labeled dPST, to the spinal cord below
T9 segment (Fig. 1a). Consequently, lumbar MNs caudal to the
T9 transection underwent degeneration with profound dendritic
atrophy (Fig. 1b). Notably, the retrograde transport of AAV-NT-
3 to the lumbar MNs significantly attenuated MN degeneration
by increasing their dendritic complexity (Fig. 1b, c). However,
such lumbar MN recovery after complete transection in NT-3-
treated mice failed to show significant functional improvement in
Basso-Mouse-Score (BMS) test, as compared to non-NT-3-
treated mice (Fig. 1d). This result indicates that the recovery of
lumbar MNs alone is insufficient to restore meaningful locomo-
tion, thus the recruitment of spared descending motor pathways
down to the lumbar MN pool remains critical for functional
recovery after SCI.
NT-3 treatment enhances supraspinal transmission after SCI.
Cognizant of the potential role of descending pathways in
recovery, we next investigated which of the spared supraspinal
pathways contributed to NT-3-induced locomotor recovery after
a thoracic contusive SCI and the potential mechanism7. We first
investigated the possible connectivity of cortico-MN and rubro-
MN circuits after SCI. Electrical stimulation in the motor cortex
or red nucleus elicited reproducible waveforms of electro-
myography (EMG) responses in sham mice (Fig. 2a, c). After the
T9 contusion, small yet detectable reflex EMG signals were still
evoked in AAV-GFP-treated mice after either motor cortex or red
nucleus stimulation (Fig. 2a, c). Notably, AAV-NT-3 treatment
elevated the EMG activity of hindlimb muscles, as reflected by
increased peak-to-peak amplitudes and decreased signal latencies
relative to those in AAV-GFP treated controls (Fig. 2a, c, e, f).
This indicates that NT-3 treatment enhanced the transmission of
supraspinal signals across the contusion to activate the lumbar
circuit. When we re-lesioned the CST by bilateral pyramidotomy
in the medulla, or re-lesion the RST by bilateral C2 lateral
hemisection at levels rostral to the T9 contusion, no EMG
responses were elicited in all groups at 1 day after the re-lesion
even with gradually increased electrical stimulation (Fig. 2b, d).
This suggests that the transmission examined in sham and con-
tusive mice was mainly due to spared supraspinal transmission to
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the lumbar motor circuit, rather than autonomous activities of
the lumbar MN circuit.
Contusion at T9 disrupts CST and RST projections below the
lesion site. The electrophysiological evaluation showed that
descending signals from both CST and RST could be used to
evaluate lumbar circuits during NT-3 treatment. These results
prompted us to assess the possible integrity of CST and RST
projections after T9 contusion. We began by injecting an ante-
rograde tracer, BDA, into the sensorimotor cortex at 6 wpi
(Supplementary Fig. 1a). In sham mice, BDA-labeled CST axons
projected to the lumbar enlargement bilaterally and their
terminals distributed extensively in the gray matter on both sides
(Supplementary Fig. 1b, c). Some terminals were in close contact
with cholera toxin subunit B (CTB)-labeled lumbar MNs and co-
localized with synaptophysin puncta, indicating direct cortico-
MN connections in adult mice (Supplementary Fig. 2a, b).
However, few, if any, BDA-labeled CST fibers were observed
caudal to the lesion in either AAV-GFP- or AAV-NT-3-treated
mice (Supplementary Fig. 2a, b). The lack of CST projections
caudal to the injury is clearly illustrated in heat maps generated
from sections between L2–L4 segments (Supplementary Fig. 1c).
Serial sections showed that BDA-labeled CST axons projected
extensively above the injury, diminished at the site of injury, and
disappeared below the level of injury (Supplementary Fig. 3a).
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Fig. 1 NT-3 failed to improve functional recovery after T9 transection. a Diagram illustrates the experimental design. A complete spinal cord transection
was made at the T9 vertebral level to transect all descending pathways. AAV-NT-3 or AAV-GFP (control) was injected bilaterally into sciatic nerves to
retrogradely transport the NT-3 to lumbar MNs. BDA was bilaterally injected into cervical segments of C5–C6 to anterogradely label the cervical
descending dPST at 6 wpi. A representative image of the boxed area (right) shows the lesion site, recognized by GFAP staining, in which BDA-labeled
(BDA+) dPST axons were completely stopped at the rostral lesion border. Scale bar= 200 μm. Compass: R, rostral; C, caudal; D, dorsal; V, ventral.
b Representative images show lumbar MN dendritic complexity from sham and T9 transected mice treated with either AAV-GFP or AAV-NT-3. Scale
bar= 200 μm. c Curve plot represents the sholl analysis of lumbar MN dendritic distribution in each experimental group. Thick lines represent the average
distribution of n= 3–4 animals per group; shaded area, 95% confidence intervals. d Line plot indicates the BMS score in three experimental groups, before
and after the T9 transection, at different time points. Note that mice receiving AAV-NT-3 treatment after the T9 transection show increased MN dendritic
arbors, but no locomotor improvement as compared to mice receiving AAV-GFP. Data are presented as mean ± SEM; n= 5–7 biologically independent
animals per group. Two-way ANOVA followed by Tukey’s multiple comparison tests. AAV adeno-associated virus, NT-3 neurotrophin-3, GFP green
fluorescent protein, BDA biotinylated dextran amines, dPST descending propriospinal tract, GFAP glial fibrillary acidic protein, MNs motoneurons. Source
data are provided as a Source Data file.
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Thus, a moderate contusive SCI at T9 completely removes CST
projections caudal to the injury.
To test the continuity of RST axons after T9 contusion, we
microinjected BDA stereotaxically into the magnocellular region
of the red nucleus (RN) bilaterally at 6 wpi to label the RST axons
(Supplementary Fig. 1d, e). Surprisingly, we found that the
moderate contusion damaged nearly all of the RST projections at
and below the level of injury, even though the BDA-labeled RST
located in the dorsolateral funiculus of spinal cord rostral to the
lesion. Few, if any, BDA-labeled RST terminals were present at
levels caudal to the T9 contusion in either AAV-GFP or AAV-
NT-3 treated mice (Supplementary Figs. 1f, 2c, d, and 3b).
Together, we found no evidence for the presence of either CST or
RST axons directly projecting into the spinal cord caudal to the
injury. Thus, functional connections between these pathways and
lumbar neural circuitry must be mediated through intermediate
pathways, such as the dPST, after SCI.
NT-3 treatment induces propriospino-MN reorganization. The
first candidate for such an intermediate pathway to relay the CST
and/or RST connectivity is the dPST, which is distributed uni-
formly over a wide area throughout the spinal cord22,23, and
serves as an intermediate relay for descending motor commands
to activate the lumbar circuit15,16,24. To examine this possibility,
BDA was injected into the rostral cervical segments (C5–C6) in
mice to label the dPST at 6 wpi in each group (sham, SCI+AAV-
GFP, and SCI+AAV-NT-3) (Fig. 3a). We found that unlike the
CST and RST, a contusive SCI caused damage to the dPST but
spared its projects to the lumbar spinal cord (Fig. 3b, c, Supple-
mentary Fig. 4a–d). Notably, retrograde transport of AAV-NT-3
to lumbar MNs did not alter dPST fiber density in the thoracic
level (Supplementary Fig. 4c, d), but significantly increased the
terminal fiber density in lumbar spinal cord, especially in the
ventral horn, where lumbar MNs reside, as compared to non-NT-
3 treatment (Fig. 3b, c, d). Accordingly, a higher density of dPST
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Fig. 2 NT-3 enhanced cortical and rubral control of hindlimb EMG response. a Schematic diagram shows EMG potentials recorded in contralateral
gastrocnemius muscle in response to electrical stimulation in the motor cortex of mice at 6 weeks after a T9 contusion. Representative examples of EMG
traces were evoked by motor-cortex stimulation in the sham, SCI+AAV-GFP, and SCI+AAV-NT-3 treatment groups after SCI. The dotted line indicates
the onset of EMG response in an AAV-NT-3-treated mouse; the arrows indicate the EMG latency. b Schematic diagram illustrates EMG activity in each
group at 1 day after bilateral pyramidotomy. c Schematic diagram shows EMG potentials recorded in the contralateral gastrocnemius muscle in response to
electrical stimulation in the red nucleus of mice at 6 weeks after the T9 contusion. Representative examples of EMG traces were plotted for each animal
group. d Schematic diagram illustrates the EMG activities in each animal group at 1 day following bilateral lateral hemisection to transect the RST at the C5
vertebral level. e Quantitative analysis of cortico-stimulation-induced EMG amplitudes and latencies of the sham (44 stimulation sites from 6 mice), SCI+
AAV-GFP (57 stimulation sites from 8 mice), and SCI+AAV-NT-3 (50 stimulation sites from 7 mice) animal groups. f Quantitative analysis of rubro-
stimulation-induced EMG amplitudes and latencies in the sham (44 stimulation sites from 5 mice), SCI+AAV-GFP (49 stimulation sites from 6 mice),
and SCI+AAV-NT-3 (45 stimulation sites from 6 mice) animal groups. The black dots represent independent stimulation sites from each group. The
yellow lines from violin plots indicate mean ± SD. The dashed lines in histograms indicate the mean line from each group. ***P < 0.001. One-way ANOVA
followed by Tukey’s multiple comparison test. EMG electromyography, CST corticospinal tract, RST rubrospinal tract. Source data are provided as a Source
Data file.
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terminals contacting lumbar MNs appeared in SCI+AAV-NT-3
than in SCI+AAV-GFP groups (Fig. 3c, d, Supplementary
Fig. 4e, f). Importantly, AAV-NT-3 treatment significantly
enhanced TrkC (a highly selective receptor for NT-3) expression
in the gray matter of lumbar spinal cord and accordingly elevated
TrkC-BDA colocalization along with BDA-labeled dPST axons, as
compared to AAV-GFP-treated controls (Fig. 3e, f).
To confirm the NT-3-mediated propriospino-MN circuit
reorganization, a retrograde multi-transsynaptic pseudorabies
virus (PRV) carrying the enhanced GFP (EGFP) was introduced
to retrogradely label the lumbar MN-related interneurons above,
at, and below the lesion (Supplementary Fig. 5a). PRV labels
different-order neurons in a time-dependent manner25. There-
fore, we first detected PRV-labeled lumbar MNs at 24 h post-
injection (Supplementary Fig. 5b). At 72 h, viral propagation is
sufficient to identify the distribution of dPNs as we observed
PRV-labeled interneurons located in the cervical level (Supple-
mentary Fig. 5c). In sham mice with PRV injection, GFP-positive
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frequently seen in the SCI+AAV-NT-3 group than the SCI+AAV-GFP group. Scale bar= 40 μm. d Bar plot indicates the relative integrated density/mm2
of BDA+ dPST fibers in the lumbar ventral horn between groups; n= 4–6 mice per group (3–5 sections per animal). e Confocal z-stacks demonstrate that
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*P < 0.05; **P < 0.01; ***P < 0.001. One-way ANOVA followed by Tukey’s post-hoc test. dPST descending propriospinal tract, TrkC tropomyosin receptor
kinase C. Source data are provided as a Source Data file.
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interneurons were distributed widely throughout the spinal cord,
mostly in the dorsal horn and intermediate zone. In contrast,
contusion injury dramatically reduced the population of retro-
gradely labeled interneurons above the lesion, where they were
found limited to intermediate laminae26. However, there was a
significant increase in PRV-labeled dPNs at the T7 segmental
level in SCI mice with AAV-NT-3 treatment, as compared to SCI
mice with AAV-GFP treatment (Supplementary Fig. 5c, d). These
results suggest that NT-3 treatment reinforced residual
propriospino-MN circuit reorganization by increasing their
synaptic connections.
The dPNs relay descending signals bypassing the lesions. To
identify whether the dPNs above the lesion could relay des-
cending commands down to the lumbar circuit, we need to first
confirm whether these pathways make connections with the dPNs
at levels above the injury. In an initial attempt, we determine the
projection of three descending pathways originating from the
motor cortex (forms the CST), red nucleus (forms the RST), and
cervical enlargement (forms the cervical dPST) on dPNs above
the level of injury. We injected the anterograde tracer, BDA, into
the motor cortex (Supplementary Fig. 6a), red nucleus (Supple-
mentary Fig. 6d), and cervical spinal cord (C5–C6, Supplemen-
tary Fig. 6g), respectively. At the same time, we retrogradely
traced lumbar MN-related dPNs at T7 (rostral to the T9 contu-
sion) by injection of PRV into the gastrocnemius muscle (Sup-
plementary Fig. 6a, d, g). In the intact spinal cord, many
BDA-labeled axons from all of the three descending pathways
terminated on PRV-labeled dPNs at T7 (Supplementary Fig. 6b,
e, h), indicating the establishment of cortico-, rubro-, and
propriospino-MN circuits within the spinal cord rostral to a T9
contusion, which are important to propagate descending signals
down to lumbar MNs. Although a T9 contusion injury reduced
the number of GFP-positive neurons rostral to the injury, the
residual PRV-labeled dPNs still made close contacts with BDA-
labeled CST, RST, and cervical dPST, which were colocalized with
synaptophysin, a presynaptic marker (Supplementary Fig. 6c, f, i).
Together with the electrophysiology data (Fig. 2), these findings
suggest that residual dPST that passes around the injury serves as
an anatomical bridge to relay supraspinal signals to lumbar MN
circuit after a T9 contusion, and these axons responded to the
NT-3 treatment.
Silencing dPNs impairs NT-3-induced locomotor recovery. To
further determine whether descending propriospino-lumbar MN
circuit reorganization was responsible for NT-3-mediated
enhancement of recovery of function, we reversibly silenced
MN-related dPNs by selective blockades of the dPN transmission
via a dual-viral infection technique23 (Supplementary Fig. 7a), a
method originally developed by Isa and colleagues27. Here, we
chose to functionally silence the neurotransmission of thoracic
dPNs rather than cervical ones due to the lack of a significant
number of PRV-labeled dPNs in cervical levels in contusive mice
(Supplementary Fig. 5c). In this study, the first vector, HiRet-
TRE-EGFP.eTeNT carrying the EGFP and enhanced tetanus
neurotoxin light chain (eTeNT) downstream of the tetracycline-
responsive element (TRE), was bilaterally injected into the L2–L4
cord level where propriospinal axon terminals innervate the
lumbar MN region (Fig. 4a, b). The second vector, Tet-On/AAV,
carrying the Tet-on sequence, a variant of reverse tetracycline
transactivator (rtTAV16), under the control of the cytomegalo-
virus (CMV) promoter, was bilaterally injected into the inter-
mediate zone of T5–T7 spinal cord to infect thoracic dPNs
(Fig. 4a, b). Three weeks after the injections, doxycycline (Dox)
was given to mice to induce the expression of EGFP-tagged
eTeNT in dPNs which were transduced by both vectors. eTeNT
would selectively silence synaptic transmission from dPNs with-
out perturbation of other descending neurotransmissions to
lumbar MNs (Fig. 4a, b).
The double-infected dPNs, visualized by EGFP expression,
were found mainly in the lateral portion of the intermediate zone
(laminae V–VII) (Fig. 4b), which were similar to the distribution
of PRV-labeled dPNs observed previously. Their longitudinal
distribution extending from T4 to T8 segments was slightly wider
than where Tet-On/AAV was injected (T5–T7) and probably
resulted from the diffusive spread of the injected vector solution.
Contusion injuries did not affect dPN distributions in the spinal
cord, but markedly reduced the number of EGFP-positive dPNs
by 60% when compared with that in sham mice (Fig. 4b). No
significant difference was found in the number of dPNs between
contusive mice with either AAV-GFP or AAV-NT-3 treatment
(Fig. 4b). To determine the functional (i.e. locomotion)
consequences following the dPNs blockage, we performed time-
course behavioral assessments (BMS, grid walking, and rotarod
tests) on each experimental group before, during, and after oral
Dox administration. After beginning Dox administration, sham
mice expressing eTeNT had profound deficits of skilled
locomotion, as revealed by increased error rate in grid walking
and reduced ability to stay on the rod in the rotarod test (Fig. 4c),
indicating dPN-mediated transmission was associated with
hindlimb locomotion in the intact spinal cord. No significant
changes were observed in the BMS score during the silencing of
dPNs (Supplementary Fig. 7b). This may be because blockage of
synaptic transmission through partial thoracic dPNs is not severe
enough to cause behavior deficits in the BMS test, or because
other descending pathways would have compensated for the loss
of control by silenced dPNs. In SCI+AAV-GFP control mice,
Dox administration caused detectable but not significant
locomotor deficits in grid walking and rotarod tasks (Fig. 4c).
In contrast, silencing dPNs in SCI+AAV-NT-3 mice signifi-
cantly impaired the skilled locomotor movements in both grid
walking and rotarod tests which had previously shown recovery
with NT-3 treatment (Fig. 4c). This result was substantiated when
we analyzed the locomotor performance of individual animals
before, during, and after Dox administration (Fig. 4c). Further-
more, we found a higher positive correlation between the
silencing-induced locomotion alterations and the number of
double infected dPNs in the SCI+AAV-NT-3 group, compared
to the poor correlation in the sham or SCI+AAV-GFP group
(Fig. 4d).
To further confirm whether the descending propriospinal
reorganization is responsible for NT-3-mediated enhanced
functional recovery, we examined mice that had received the
NT-3 treatment after two, spatially separated hemisections at T7
and T12, on opposite sides of the spinal cord, to test the effect of
transecting all descending axons while leaving those contiguous
propriospinal circuits (Fig. 5a, b). We unilaterally injected BDA
into the right side of the spinal cord at T9 at 6 weeks after the
staggered lesions and found a significant increase in fiber density
of BDA-labeled dPST sprouting from right to left side of the
lumbar segments in AAV-NT-3-treated mice, relative to AAV-
GFP-treated control mice (Fig. 5c). In accordance, more dPST
fibers were found in close apposition with CTB-labeled
lumbar MNs at the left lumbar segments in AAV-NT-3-treated
mice as compared to the AAV-GFP controls (Fig. 5d). Consistent
with the anatomical differences, the lesioned mice with AAV-GFP
treatment had limited left hindlimb movement even at 6 wpi, and
the left gastrocnemius muscle was quiescent after transcranial
magnetic motor evoked potential (tcMMEP) stimulation (Fig. 5e).
However, the lesioned mice that received NT-3 treatment had
some extent of recovery in stepping ability, and the gastrocnemius
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muscle in the left hindlimb showed consistent and detectable
tcMMEP responses, despite abnormal latency and amplitude, as
compared to sham intact mice (Fig. 5f). Collectively, these
findings suggest that the descending propriospino-lumbar MN
circuit reorganization is functionally required for NT-3-induced
functional recovery.
Silencing monoaminergic pathways produces no locomotor
deficits. In addition to descending propriospinal pathways, AAV-
NT-3 transfection also enhanced serotonin (5-HT, i.e. ser-
otoninergic) and tyrosine hydroxylase (TH, i.e. dopaminergic)
fiber density in the lumbar spinal cord (Supplementary Fig. 8),
which corroborated our previous report using a similar
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approach7. Studies have shown that both descending ser-
otoninergic and dopaminergic pathways are implicated in the
initiation of locomotion28–31. Nevertheless, a difficult question
remains: are these pathways functionally related to NT-3-induced
locomotor recovery? To answer this, we used a similar double-
viral blockage technique as we did for silencing dPNs. To selec-
tively target the serotonin-MN circuit, we performed stereotaxic
microinjections of HiRet-TRE-EGFP.eTeNT into the lumbar MN
area (L2–L4) innervated by serotonergic axon terminals, and Tet-
On/AAV into the caudal raphe nuclei where the 5-HT neurons
are located (Supplementary Fig. 9a). More than 1000 double-
transfected GFP-positive cells were found in the caudal brainstem
in sham mice while less than 300 GFP-positive neurons were
detected in the T9 contusive mice. No significant difference was
noted in the number of GFP-positive neurons between SCI+
AAV-GFP and SCI+AAV-NT-3 groups (Supplementary Fig. 9a,
b). We used 5-HT immunohistochemistry to confirm the
expression of serotonin in these cells. Any double-labeled (i.e.
GFP and 5-HT) neurons would represent a serotoninergic neuron
whose axon has projected to the lumbar cord. We found ~200
GFP-positive cells colocalized with 5-HT immunoreactive neu-
rons from the raphe nuclei in sham mice but only ~50 GFP-
labeled neurons expressed 5-HT in the raphe nuclei after the T9
contusion regardless of the treatment (Supplementary Fig. 9a, b).
With 4 days of Dox administration, the mice in the sham group
experienced a transient and slight motor deficit in grid walking
test, but no detectable change in the rotarod test. Despite this
deficit, contusive mice with either AAV-NT-3 or AAV-GFP
treatment showed no problematic change in locomotion after
silencing 5-HT projections (Supplementary Fig. 9b).
To selectively target the dopamine-MN circuit, the HiRet-TRE-
EGFP.eTeNT was injected into lumbar MN region, and the Tet-
On/AAV was stereotaxically injected into the A11 region within
the posterior diencephalon, which has been known to give rise to
descending dopaminergic axons and contribute to motor
control25,29,32 (Supplementary Fig. 9c). The double viral infection
was confirmed by counting the GFP-labeled cells in the A11
region. We found that ~500 and ~90 GFP-positive cells were
detected in the sham and T9 contusion mice, respectively. No
difference in the number of GFP-positive neurons was found
between the SCI+AAV-GFP and SCI+AAV-NT-3 groups. We
did TH immunohistochemistry to identify classes of GFP-labeled
cells within the A11 and found ~70 and ~15 GFP-positive cells
were also positive for TH immunoreactive in sham and contusive
mice, respectively. No difference in the number of GFP and TH
double-infected neurons was found between SCI+AAV-GFP
and SCI+AAV-NT-3 groups (Supplementary Fig. 9c, d). Similar
to the effect of blockage of serotoninergic transmission, A11
inactivation failed to induce the impairment of hindlimb
locomotion between AAV-GFP and AAV-NT-3 treatments
(Supplementary Fig. 9d). Even in sham mice, no change was
found in locomotor behavior following Dox administration.
Collectively, these results suggest that the spared serotoninergic
and dopaminergic pathways play a minor role in NT-3-mediated
enhancement of locomotor recovery after contusion.
NT-3 reverses MN degeneration via dendritic regrowth rather
than stabilization. To better understand how AAV-NT-3
treatment mediates remodeling of propriospino-MN circuit
following SCI, we first examined NT-3 expression by ELISA
assay in the lumbar cord (L2–L4) at different time points fol-
lowing sciatic nerve AAV-NT-3 injections after the T9 contu-
sion. Time-dependent NT-3 expression was significantly
increased at 3 wpi, plateaued at 4 wpi, and maintained high
levels of expression up to 6 wpi, the longest time point studied
(Fig. 6a). We then chose 2 wpi and 4 wpi as two critical time
points to examine NT-3-mediated remodeling of the
propriospino-MN connections. The lumbar MNs were retro-
gradely labeled with CTB, while the dPST axons were ante-
rogradely labeled with BDA (Fig. 6b). We found that NT-3
treatment had little effect on SCI-induced MN dendritic atro-
phy and synaptic stripping (of dPST axons) at 2 wpi, but pro-
moted MN dendritic regrowth and new synaptic formation
(from dPST axons) at 4 wpi (Fig. 6b, c, d). This suggests that the
NT-3 effect on MN neurocircuit changes is a result of stimu-
lating dendritic regrowth and synaptic reformation rather than
stabilizing the existing dendritic morphology and synapses.
However, such an explanation could still be challenged by the
fact that NT-3 expression was relatively low at 2 wpi as com-
pared to 4 wpi. To address this, we treated the mice with AAV-
NT-3 at 2 weeks prior to the T9 contusion and then assessed
MN dendritic changes at 2 wpi and 4 wpi. We found that, at 2
wpi, MN dendritic atrophy was still present and NT-3 pre-
treatment had little effect on preventing it. At 4 wpi, however,
MN dendritic ramifications appeared regrowing to a similar
extent as with the NT-3 post-treatment (Fig. 6e). Thus, a
similar pattern of MN dendritic atrophy occurred at 2 wpi
followed by dendritic restoration at 4 wpi, irrespective of when
NT-3 was given (pre- or post-injury), indicating that the NT-3
effect is mediated via promoting regrowth of atrophied den-
drites rather than preventing existing dendrites from injury-
induced dendritic atrophy. Likewise, NT-3 treatment also
promoted the synaptogenesis of sprouted dPST axons and
dendrites with lumbar MNs.
Fig. 4 Thoracic dPNs functionally contributed to NT-3-mediated locomotor recovery. a A schematic drawing shows the experimental design. The
contusive mice with either AAV-GFP or AAV-NT-3 treatment received two viral injections, i.e. HiRet-TRE-EGFP-eTeNT into the L3–L4 segments and Tet-
On/AAV into the T5–T7 segments at 6 wpi. Three weeks later, Dox was administered to induce the expression of eTeNT. Locomotor function was
evaluated using BMS, grid walking, and rotarod assessments before, during and after Dox administration. b A diagram shows the strategy to silence the
thoracic (T5–T7) dPNs with dual virus injections. Insets of the boxed area indicate the transverse view of Tet-On/AAV injections and a representative
image of GFP+ dPNs infected by dual viruses. Scale bar= 100 μm. Bar plot reveals the total number of dual-virus infected, GFP+ dPNs in T5–T7 spinal
segments among three groups with individual values for each animal. Data are presented as box plots with center lines indicating medians, boxes
representing 25th to 75th percentiles, and whiskers representing data points within 1.5 times the IQR. n= 9–10 animals per group. ***P < 0.001; one-way
ANOVA followed by Tukey’s post-hoc test. c Line plots show changes of hindlimb locomotor function with grid walking and rotarod testing before, during
and after Dox administration. Data are presented as mean ± SEM. n= 9–10 biologically independent animals per group. *P < 0.05, **P < 0.01, ***P < 0.001
(SCI+AAV-GFP vs SCI+AAV-NT-3); two-way ANOVA followed by Tukey’s multiple comparisons test. Bar plots detail alterations in locomotor
behaviors, with individual animals from each experimental group, in response to Dox treatment (n= 9–10 animals per group). *P < 0.05; **P < 0.01; one-
way ANOVA followed by Tukey’s post-hoc test. d Scatter plots indicating the correlations of the number of double-infected GFP+ dPNs with Dox-induced
locomotor deficits in grid walking and rotarod assessments. The middle lines in scatter plots indicate the regression lines and the shades represent 95%
confidence intervals. SCI spinal cord injury, BMS Basso Mouse Scale, Dox doxycycline, wpi weeks post-injury. Source data are provided as a Source
Data file.
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Discussion
In this study, we found that, upon recovery of lumbar MNs,
mediated by the NT-3 therapy, the sprouting and sparing of
descending pathways projecting to the lumbar spinal cord was
essential for locomotor recovery after a T9 contusion. We then
found that the contusive SCI interrupted both the CST and RST
projections at the site of injury, but spared the descending pro-
priospinal system which conveyed the corticospinal and
rubrospinal signals down to the lumbar MNs. Pathway-selective
silencing of neural transmission in three, spared, descending
pathways (i.e. the serotoninergic, dopaminergic, and dPST)
revealed that the dPST was the primary pathway that functionally
accounts for the NT-3-mediated functional recovery. Lastly, our
time-course study revealed that NT-3-stimulated propriospino-
MN neurocircuit reorganization occurred mainly via promoting
regrowth of atrophied dendrites rather than preventing existing
dendrites from injury-induced dendritic degeneration. To our
knowledge, this is the first study to dissect functional pathways
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that innervate the lumbar neurocircuit, as well as the first study to
reveal a critical role of descending propriospinal-lumbar MN
circuit for enabling motor control after a rostral, contusive SCI.
Locomotor movements in vertebrates are not only generated by
activities in spinal neurons themselves but also regulated by
descending pathways from supraspinal areas1,2. SCIs can
profoundly interrupt supraspinal projections to the lumbar circuit
leading to locomotor deficits. Although lesioned descending
axons have limited ability to reconnect to their targets by
long-distance regeneration33, the reorganization of spared corti-
cospinal14, reticulospinal34, and intraspinal15,35 projections can
provide an extensive capacity for functional recovery which
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represents an attractive target for therapeutic manipulation. In
line with this, a crucial question in this study is whether des-
cending pathways are responsible for NT-3-induced functional
recovery, and if so, which pathway plays a major role. To answer
this question, we took advantage of the complete transection
model followed by retrograde transport of NT-3 to lumbar MNs.
We found that, although the NT-3 treatment reversed MN den-
dritic atrophy, it failed to produce significant motor recovery in
the absence of descending motor control, after the T9 total
transection. This suggests that, in addition to preventing lumbar
MN atrophy, restoring descending motor control of lumbar MN
circuitry is required for NT-3-mediated recovery after SCI. Thus,
enhancing the plasticity of descending pathways (particularly that
of the contusion-spared, NT-3-sensitive dPST) and restoring
caudal-to-injury lumbar MN dendritic morphology and synaptic
formation are indispensable for NT-3-induced locomotor recov-
ery after a rostral thoracic SCI.
Our in vitro and in vivo NT-3 ELISA results showed that NT-3
was released from lumbar MNs to the local environment.
Examination of the axonal distribution of the CST, RST, and
dPST showed that NT-3 had no spatial diffusion effect on axon
sprouting or regeneration at or above the lesion site. The effect of
NT-3 is confined within the lumbar spinal cord, indicating that
only residual pathways that reach the lumbar region account for
NT-3-induce recovery. By contrast, our moderate contusive SCI
profoundly disrupted both the CST and RST projections to
lumbar MNs. Despite no residuals, their descending neuro-
transmissions were preserved downstream14,35, evidenced by
electrophysiological recordings, suggesting alternative routes that
conduct corticospinal and rubrospinal comments down to the
lumbar MN circuit.
Both our previous7 and current data showed that mono-
aminergic (dopaminergic and serotonergic) pathways were spared
after a spinal cord contusion and that they responded to the NT-3
treatment by increasing local collateral sprouting. However,
silencing synaptic transmission of these neurons by a dual virus
technique failed to alter locomotor performance. Since a small
number of descending monoaminergic neurons were targeted in
the silencing experiment, two possibilities exist concerning the
functional roles of the spared monoaminergic pathways. One
possibility is that the NT-3 treatment induced monoaminergic
axons to increase their terminal sprouting in the lumbar cord
post-injury, but they are not functionally engaged in locomotor
recovery. Alternatively, the residual monoaminergic pathways
may contributed to NT-3-induced recovery, but the double-
infection technique applied here infected too few monoaminergic
neurons to show an functional effect. For the second possibility,
this limitation was not observed in sham animals where many
GFP-positive neurons were found within dopaminergic and ser-
otonergic brain regions. In that group, we still did not observe
significant locomotor deficits during Dox administration, sug-
gesting that these pathways may play a minimal role in the
recovery after SCI. In addtion to monoaminergic pathways, lit-
erature reported that the reticulospinal tract and the vestibu-
lospinal tract may also be spared after a spinal contusion,
and that both pathways show growth response to neurotrophic
factor modulation, such as GDNF36,37 and BDNF24,38, relay the
cortical commands downstream and improve recovery after
SCI14,34. In our contusion SCI model, as cortical projections may
reroute to subcortical regions, and monoaminergic path-
ways from the brainstem play limited roles, an influence of either
reticulospinal tract or vestibulospinal tract, or both, on NT-3-
mediated functional recovery could not be excluded. This ques-
tion could be addressed in future studies using similar approaches
as presented in the current study.
Since supraspinal pathways are not directly responsible for NT-
3-mediated recovery after SCI, we determined whether this
enhancement of recovery was due to an intermediate pathway
through dPNs, which has been implicated in the control of
forelimb and hindlimb behavior39–42. Courtine et al.15, and
Bareyre et al.35, previously reported that propriospinal-detour-
pathways, bypassing supraspinal commands around the lesion
site, were able to mediate spontaneous functional recovery and
supraspinal control of stepping after interruption of long des-
cending supraspinal pathways in mice. Such an anatomical fea-
ture and astonishing plasticity of dPNs have made them attractive
targets for treatment after SCI17,43. Presently, the accepted
medical practices, including activity-based rehabilitation and
epidural electrical stimulation, are based upon the concept of
activating and promoting extensive reorganization of residual
neural pathways that improve locomotion44–46. In line with these
findings, we found that dPNs that bypass the lesion received their
inputs from various descending pathways such as the CST, RST,
and cervical dPST, down to the lumbar MNs. These results also
corroborate other observations in intact22,40 and injured spinal
cords34,35. We then found that residual dPST axonal terminals
increased their spouting at the lumbar level and enhanced their
synaptic connections with lumbar MNs in response to the ret-
rogradely transported NT-3 in lumbar MNs. Blockade of synaptic
transmission through the dPNs perturbed the NT-3-mediated
recovery, suggesting that dPNs and the propriospino-lumbar MN
circuit contribute to the enhancement of locomotor recovery in
mice treated with NT-3 after SCI, and this was confirmed by our
staggered double hemisection experiments. Another study notes
that such synaptic plasticity and circuit reorganization of PNs
after SCI are well conserved across mammals47. Experiments in
Fig. 6 NT-3 induced neuroplasticity of lumbar MNs following contusion. a Bar graph shows local NT-3 expression levels, measured by ELISA, in lumbar
cord before and after contusions followed by AAV-NT-3 treatment. Data are presented as mean ± SEM; n= 3–4 mice per each time point; ***P < 0.001 vs
baseline (before SCI). One-way ANOVA followed by Tukey’s post-hoc test. b Representative images show synapse-like contacts (arrowheads) between
BDA+ dPST axons and CTB+ lumbar MNs in sham and contusive mice with AAV-NT-3 post-treatment at 2 and 4 wpi. Scale bar= 10 μm. c Quantitative
analysis of the number of triple-labeled appositions between BDA+ dPST, CTB+ MNs, and synaptophysin per each MN per section among three groups.
Dots in violin plots represent triple appositions from 3–4 mice in each group. The yellow lines indicate mean ± SD. **P < 0.01, ***P < 0.001; one-way
ANOVA followed by Tukey’s post-hoc test. d Representative images show lumbar MN dendritic complexity in the three experimental groups. Curve plot
represents sholl analysis of MN morphology among groups. Thick lines represent the average distributions of MN dendrites for each experimental group
(n= 3 mice per group); shaded areas represent 95% confidence intervals. Line plot details the difference in the dendritic complexity of MNs at distance
from somas between 50 and 160 μm. Data are presented as mean ± SEM. Two-way ANOVA followed by Tukey’s post-hoc test. e Representative images
show MN dendritic complexity in sham and T9 contusion mice with AAV-NT-3 pre-treatment and MN dendritic morphology examined at 2 and 4 wpi.
Curve plot represents sholl analysis of MN dendritic distribution in the three groups. Thick lines represent the average distributions of MN dendrites among
groups (n= 3 mice per group); shaded areas represent 95% confidence intervals. Line plot details the difference in the dendritic complexity of lumbar MNs
at distances from somas between 50 and 160 μm. Data are presented as mean ± SEM. Two-way ANOVA followed by Tukey’s post-hoc test. Source data
are provided as a Source Data file.
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nonhuman primates and humans show that dPNs contribute to
recovery after CST lesions or SCI48–51. Therefore, our findings
support the idea that NT-3-mediated enhanced functional
recovery occurs through the reorganization of the spared dPST.
Also, when targeting the plasticity of the dPST, we may ask
whether cervical or thoracic dPNs are essential for functional
recovery. In our study, we conclude that the thoracic dPNs are
essential at least beneficial. However, it would still be interesting
to systematically dissect which dPNs play a more significant role,
and what will be the consequence if both dPNs are silenced at the
same time via dual viral technique in the future.
Neurotrophins are a family of proteins that is essential for the
development and maturation of the nervous system, including the
regulation of neuronal survival, neurite outgrowth, synaptic
plasticity, and neurotransmission. Among them, NT-3 mRNA is
highly expressed in the developing spinal cord in MNs but
decrease in the adult spinal cord52,53. NT-3 is essential for MN
survival, target finding, innervation, and synapse formation,
mainly during development and early postnatal maturation52,54.
We hypothesize that vector-induced NT-3 expression in adult
MNs may allow us to mimic some of the observations seen during
development. In addition, published evidence shows that the
expression of TrkC receptor that NT-3 binds with the highest
affinity was not limited to MNs, but was seen on the vast majority
of neurons throughout the gray matter of spinal cord52,55,56,
suggesting that other populations of neurons also respond to the
NT-3 expression. A body of studies also demonstrate that local,
sustained expression of NT-3 supports the plasticity of CST20,57,
spinal neuronal survival, and regeneration58,59. More impor-
tantly, NT-3 can also serve as chemoattractive guidance for
regenerated axons to establish their projection, find their targets,
and reform appropriate connections58,60. Together, the rationales
discussed above guided us to take advantage of AAV-NT-3 as a
beneficial therapeutic treatment for targeting lumbar MNs after
SCI. In the current study, we demonstrate that NT-3 expression
via AAV-directed gene therapy restored lumbar MN dendritic
morphology, increased remodeling of local neurocircuit, and
promoted significant locomotor restoration following a rostral-
level thoracic contusion.
Several studies showed that neurotrophins, released from
grafts/neurons or provided exogenously, are neuroprotective or
pro-regenerative for recovery after SCI20,21. Determining the
specific role of NT-3 in mediating MN recovery is very important
for translating NT-3 treatment into preclinical and/or clinical
settings. We addressed this question by assessing the dendritic
features of lumbar MNs in response to NT-3 with either pre-
treatment (i.e. before contusion) or post-treatment (i.e. after
contusion). We observed lumbar MN dendritic withdrawal at
2 wpi and regrowth at 4 wpi after SCI, irrespective of if NT-3 gene
therapy was applied as pre- or post-treatment. This result indi-
cates that retrograde transport of NT-3 to the lumbar MNs does
not prevent SCI-induced lumbar MN dendritic atrophy, but
rather facilitate lumbar MN dendritic regrowth after their initial
withdrawal. This mechanistic insight implies that NT-3 gene
therapy is potentially applicable to a broad range of patients who
are suffering from subacute or long-term chronic SCIs, even after
rehabilitation is initiated. As physical activity is capable of sti-
mulating NT-3 synthesis which modulates sensory and motor
function8,61, we speculate that, when combined with physical
rehabilitation, AAV-NT-3 gene therapy can further boost neu-
roplasticity of residual neural pathways and facilitate robust
functional recovery.
CNS-directed AAV gene therapies have produced promising
pre-clinical and clinical results by the mechanism of inserting,
replacing, or deleting genes. Substantial evidence from clinical
trials has supported the safety, tolerability, and efficacy of AAV2
as a promising treatment approach for targeting the CNS62,63. In
addition, NT3 was shown to be safe and well-tolerated in phase I
and II clinical trials for CNS disorders64,65. However, no clinical
studies have been initiated to investigate the effectiveness of NT-3
for promoting motor functional recovery after SCI. In our animal
studies7, we took advantage of the human NT-3 transgene which
could effectively be translated into clinical therapy. Thus, our
preclinical study paves the way for AAV-NT-3 gene therapy as a
potential treatment for the functional restoration of SCI patients.
In conclusion, our study demonstrates that NT-3-stimulated
propriospino-lumbar MN neurocircuit improved functional
recovery after a rostral-level thoracic contusive SCI. Thus, this
study opens new perspectives to guide spinal cord repair inter-
ventions in the future.
Methods
Animals. Adult female C57BL/6J mice were purchased from the Jackson Labora-
tory (8–10 weeks old, 18–22 g body weight). All animal experiments were per-
formed in compliance with all relevant ethical regulations for animal testing and
research and in accordance with animal protocols approved by the Institutional
Animal Care and Use Committee of Indiana University School of Medicine
(IACUC #11011 and #18081) and Institutional Biosafety Committee (IBC #1556).
The experimental protocols strictly followed the guidelines of National Institutes of
Health (NIH) on the use of laboratory animals. To achieve various goals in this
study, we have induced three different thoracic-level SCI models, including com-
plete T9 transection, moderate T9 contusion, and staggered (T7 and T12) lateral
hemisection. In each injury model, mice were randomly divided into three
experimental groups. Group 1: sham (laminectomy)+ saline; Group 2: SCI+
AAV-GFP; Group 3: SCI+AAV-NT-3. Either saline or AAV-GFP or AAV-NT-3
(1 μl) was bilaterally injected into pre-demyelinated sciatic nerves in each group
animal after surgery, respectively7.
AAV viral preparation and injection. Recombinant adeno-associated virus 2
(AAV2) carrying GFP (AAV-GFP, 1.0 × 1013 viral particles/ml; Temple University,
Philadelphia, USA) was used as a control. Human NT-3 subcloned into an AAV
vector cassette under the control of the chicken-beta actin (CBA) promoter and
containing a polyadenylation signal from human B-globin gene was prepared by the
Dr. George Smith Lab (AAV-NT-3; 1.0 × 1012 viral particles/ml; Temple University,
Philadelphia, USA)7. Five days after transient demyelination with lysolecithin (Fischer
Scientific, Pittsburg, PA; 0.5ml in 1% phosphate-buffered saline (PBS)), both sides of
the sciatic nerves were injected with 1 μl of either AAV-GFP or AAV-NT-3 using a
10-μl Hamilton syringe attached to a finely pulled capillary and the injection tip was
held in place for an additional 2min to avoid the viral leakage.
Surgical procedures and animal care. For all surgical procedures, animals were
anesthetized with ketamine (17.2 mg/ml)/xylazine (0.475 mg/ml)/acepromazine
(0.238 mg/ml). After surgery, mice received subcutaneous administration of
buprenorphine (0.01–0.05 mg/kg every 8–12 h for 3 days) for pain release and
0.5 ml of saline for hydration. The mice were then returned to clean home cages
that were partially placed on a heating pad until they fully recovered from the
anesthesia. Manual bladder expression was performed twice daily until the bladder
emptying by reflex was established.
To produce a spinal cord transection model at T9, a laminectomy was exposed
at the 9th thoracic vertebral level, the dura was ruptured with a 30-gauge needle,
and the cord was transected with Noyes spring scissors (Fine science tools, Canada)
throughout the entire width and depth of the spinal cord. In all cases, a customized
microknife was used to retrace the lesion to ensure the completeness of the lesion.
To produce a contusive SCI model at T9, mice were placed on their ventral
surface in a U-shaped stabilizer66. After a T9 laminectomy, mice received a T9
contusion using the Louisville Injury System Apparatus (LISA, Louisville, KY) with
a 0.5-mm diameter tip at a velocity of 1.0 m/s. The severity and consistency of the
injury were verified by checking the bruise on the spinal cord, the injury
parameters provided by the LISA software66, and initial behavioral assessments.
For bilateral pyramidotomy, the mouse was placed in a supine position and a
midline incision was made to the ventral neck to expose the trachea. Blunt
dissection was then operated until the ventral surface of the skull was reached. To
gain access to the underlying pyramid, a bilateral craniotomy was made in
basioccipital bone by using a micro drill, which was attached to steel burr with a
ball-size of 0.6 mm (Stoelting, Item No. 58610). After the dura was incised
longitudinally by a 32-gauge needle, a bilateral cut was then made in the pyramid.
The pyramidotomy on each side was ~1.0 mm wide spanning the width of the
pyramid and 0.5 mm deep with a modified fine scalpel perpendicular to the basilar
artery to interrupt the descending CST axons.
To bilaterally transect the RST projections, a laminectomy was made to expose
the dorsolateral aspect of the spinal cord as well as the dorsal roots of C3 and C4
(ref. 25). The dura matter was opened by a bent 32-gauge needle and the lateral part
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of the dorsal lateral funiculus was then transected in a depth of 1 mm from the
spinal cord dorsal surface with a modified fine scalpel mounted on a blade holder.
The procedure of T7 and T12 staggered double hemisection was similar to that
described elsewhere15. Briefly, a midline incision was made over the thoracic
vertebrae, followed by a T7–12 laminectomy. For the lateral hemisection, we
inserted a custom-made half-open needle (32-gauge) from the midline down into
the spinal cord to guide both a micro-scissors and a scalpel to interrupt the half-
side of the spinal cord through the midline.
Anatomical tracing. To anterogradely label the projection of CST axons to the
spinal cord, mice with craniotomy over the motor cortex were placed in a ste-
reotaxic frame (Stoelting, USA) and injected with 0.5 µl of 10% BDA w/v in sterile
saline (MW 10,000, Invitrogen, USA) into one of 10 total sites (5 sites/side) with
the following coordinates: mediolateral (ML) coordination: 1.5 mm lateral to the
bregma; anteroposterior (AP) coordination from the bregma: −1.0, −0.5, 0, −0.75,
and 1.5 mm; dorsoventral (DV) coordination: 0.5 mm from the cortical surface.
The BDA was delivered by a 10-μl Hamilton syringe, at a rate of 0.1 µl/min,
controlled by a digital stereotactic injector (Item: 51709, Stoelting Co. USA). After
each injection was completed, the injector tip was left in the cortex for an addi-
tional 5 min to ensure that the BDA solution adequately penetrated the tissue
without leaking. Two weeks later, mice were anesthetized and perfused with 4%
paraformaldehyde for further anatomical analysis.
For anterograde tracing of RST25, a 10% BDA solution was injected bilaterally
into the red nucleus (3.15 and 3.65 mm posterior to the bregma, 0.6 mm lateral to
the midline, all at a depth of 3.6 mm from the cortex surface). Each injection site
was administered 0.5 µl of BDA within 5 min and the glass needle was left in place
for an additional 5 min before removal. Animals were sacrificed 2 weeks later.
For bilaterally tracing cervical and thoracic dPST axons, we stereotaxically
injected 10% BDA solution into the intermediate gray matter of C5 and T7 cord
segments. The injection coordinates were as follows: 0.5 mm lateral to the midline
and 0.9 mm deep from the dorsal surface of the C5 cord segment; 0.3 mm lateral to
the midline and 0.6 mm deep from the dorsal surface of the T7 cord segment,
respectively. For unilaterally labeling thoracic dPST axons in the staggered double
hemisected spinal cord (T7 and T12), 2 × 0.3 μm of 10% BDA was injected into the
right side of T9/T10 segments with the same coordinates as described in the
labeling of T7 thoracic dPNs. The second BDA injection was placed 0.5 mm caudal
to the first one. Mice were kept for an additional 5–7 days before sacrifice.
To retrogradely label lumbar MNs, either AAV-GFP or Alexa Fluor 488
conjugates of CTB (2% solution, Invitrogen, USA) was injected bilaterally into both
of the sciatic nerves of mice at 6 weeks following SCI. Mice were kept for 7 days
after receiving the tracer injection.
For transsynaptic tracing of MN-related dPNs, PRV-152 (gift from Dr. Lynn W.
Enquist’s lab at Princeton University) was bilaterally administered at three different
sites of the gastrocnemius muscle, using a 10-μl Hamilton syringe fitted with a 30-
gauge needle, according to the existed protocol25. At 24, 48, and 72 h post-
inoculation, animals were perfused with 0.9% saline followed by 4%
paraformaldehyde, to determine the different order of PRV-labeled neurons in the
spinal cord.
Stimulus-triggered EMG recordings. To measure evoked EMG potentials in
tibialis anterior muscles, a craniotomy was made to allow the electrodes to access the
M1 motor cortex or the red nucleus. The penetration points in the motor cortex were
chosen from 1 to −1mm caudal, 0.5 mm lateral to the bregma with a depth of
0.6mm from the surface, while the penetration points in the red nucleus were chosen
from −3 to −4 mm caudal, 0.6 mm lateral to the bregma with a depth of 3.6mm
from the surface. Electrical stimulation was delivered using a tungsten bipolar elec-
trode (Microprobes, USA) via an isolated stimulator (A-M system, USA). The elec-
trical stimulation is consisted of 7 bipolar pulses, each being 200 μs in duration, at a
frequency of 333Hz, and repeated every 2 s. The stainless-steel wire was inserted into
the contralateral tibialis muscle for recording the EMG signal. The EMG activities
were amplified by a differential AC amplifier (model 1700, A-M system, USA) and
converted as an analog signal via an analog-to-digital converter. For each single
penetration site, 20 stimulation sweeps were recorded. The non-responsive stimulus
site which failed to produce any response within a range of current from 0.5 μA to
500 μA was switched to next at a distance of 0.3mm along with the rostrocaudal axis
relative to bregma. Signals with movement artifacts were excluded. Only animals with
stable EMG responses were included in this experiment.
Double virus-mediated silencing experiments. HiRet-TRE-EGFP.eTeNT
(2.19 × 107 TU/ml) and AAV2-CMV-rtTAV16 (AAV-Tet/On, 1.2 × 1013 GC/ml)
were constructed and pre-tested in Dr. George Smith’s lab23. To assess the lumbar
cord, musculature was cleared from the T11–T13 vertebral bodies, and laminec-
tomies were performed to expose the L1–L4 spinal cord. HiRet-TRE-EGFP.eTeNT
was injected into the ventral horn of L2–L4 segments with three separate sites on
each side of the spinal cord. Injections were made at 0.6 mm lateral to the midline
and a depth of 1.1 mm from the dorsal surface, with a volume of 0.5 µl per each
site. For targeting the cell bodies of dPNs, serotoninergic neurons or dopaminergic
neurons, AAV-Tet/On was injected into the T5–T7 spinal cord, raphe nuclei, or
the midbrain A11 region, respectively. Injection coordinates for T5–T7 spinal cord
were 0.3 mm lateral to the midline and 0.6 mm deep from the dorsal surface of the
spinal cord (six injections total, 0.5 µl per injection). Injection coordinates for raphe
nucleus were −5.4, −5.9, −6.4 mm caudal to bregma, 0 mm along the midline, and
−5.6 mm ventral from the surface of the cerebellum (three injections total, 0.5 µl
per injection). Injection coordinates for the midbrain A11 region were −1.9 mm
caudal, ±0.6 mm mediolateral to the bregma, and −4.6 mm deep from the dorsal
surface of the midbrain (two injections total, 0.5 µl per injection). All injections
were done using a digital mouse stereotaxic instrument (Stoelting, USA) fitted with
a beveled, pulled glass needle, at a speed of 0.1 µl/min, the needle was held in place
for 5 min before being slowly retracted. After tracer injections, all animals were
maintained for an additional 3 weeks before the administration of Dox was initi-
ated. The Dox (2 mg/ml) was added into the drinking water with 1% sucrose. Mice
from all three experimental groups (sham, SCI+AAV-GFP, and SCI+AAV-NT-
3) were tested by using BMS7,67, grid walking68, and rotarod7,68 behavioral
assessments before Dox administration (baseline), during Dox administration
(4 days after initiation), and 7 days after the cessation of Dox administration.
Behavioral assessments. The BMS test was performed to evaluate the overall
basic locomotor performance7,67. Briefly, mice were placed in an open field (dia-
meter: 42 inches) for 4 min per each trial. Two trained observers who were blinded
to experimental groups judged the BMS score on a scale of 0–9 (0, complete hind
limb paralysis; 9, normal locomotion), which is based on hind limb movements
made in an open field including hind limb joint movement, weight support, plantar
stepping, coordination, paw position, and trunk and tail control.
For the grid walking test, a mesh metal grid setup (12 mm × 12mm) was used to
monitor skilled locomotor performance68. Each mouse was placed in the center of
the mesh grid and the hindlimb locomotion on a grid was evaluated by two
experimenters who were blinded for the animal groups over 3 min, with one person
counting the total number of footsteps while the other counting the number of
times that each of the hindlimbs fell through the grid holes.
For the rotarod test (IITC Life Science, USA)7, the pre-trained animals were
placed in the accelerating lanes of rotarod from 3 to 15 revolutions per minute
(rpm) over 2 min with a total of five trials per session. The latency of mice
maintaining themselves on the rotating rod was recorded based on when they fell
off for each trial and averaged into a final score per session.
NT-3 ELISA. The NT-3 ELISA assay was performed to assess NT-3 expression
levels before and after SCI7. Briefly, the lumbar spinal cord was quickly dissected
from the mouse and frozen in a dry ice/ethanol bath and kept at −80 °C for future
analysis. NT-3 ELISA (Human NT-3 DuoSet ELISA, R&D Systems, USA) was
performed with duplicates according to the manufacturer’s protocol to measure the
secreted NT-3 protein in vivo. NT-3 concentration was calculated based on a
linearized standard curve ranging from 0 pg/ml to 600 pg/ml.
BDA staining. The 30-µm-thick sections were incubated with avidin-biotin-
peroxidase (Vectastain R.T.U. Elite ABC Reagent, SAT700, PerkinElmer, USA) for 1 h.
Biotinyl tyramide (PerkinElmer) was diluted to 1:100 with amplification diluent, then
placed on the sections for an additional hour after the wash. The sections were then
incubated with Extra-Avidin@ TRITC (Sigma, USA, 1:200 in 0.3% PBST) for 2 h.
Lastly, the sections were washed again and coverslipped with SouthernBiotech
Fluoromount-G mounting medium (Cat. No. 0100-01, SouthernBiotech).
Immunofluorescence staining. For immunofluorescence staining, 30-µm-thick
frozen sections were incubated with the following primary antibodies: rabbit anti-
serotonin (5-HT, 1:2000, Sigma #S5545), rabbit anti-TH (1:500, Millipore #AB152),
rabbit anti-tropomyosin receptor kinase C (TrkC, 1:500, Abcam ##ab43078), and
mouse anti-synaptophysin (Syn, 1:1000, Millipore #MAB5258), rabbit anti-glia
fibrillary acidic protein (GFAP, 1:1000, Abcam, #ab7260) and goat anti-cholera
toxin B (CTB, 1:2000, List Biological Laboratories, #703). Signal was detected with
the corresponding second antibodies conjugated to Alexa Fluor 405 or 488 or 594
fluorescence (1:1000, Invitrogen).
Sholl analysis. To measure the detailed topologies of the lumbar MN dendrites
among different experimental groups across different time points, the sholl analysis
was applied on GFP-labeled MNs by using an open-source software, ImageJ (NIH,
USA). Briefly, a series of circles with increasing radii (10 µm apart) centered in the
MN pools. The number of the intersections of MN dendrites with each concentric
circle at an incremental distance was counted automatically by ImageJ, and the
associated curve plot demonstrated the number of intersections at various distances
from the MN cell body.
The topography of CST and RST terminations. To analyze the CST and RST
topographic distribution within the gray matter in the lumbar enlargement, BDA-
positive images were grouped in Photoshop software (Adobe System, USA) where
the size of the gray matter, and associated contours, were normalized to standar-
dized dorsoventral and mediolateral lengths of the spinal cord. Subsequently, the
images were aligned and processed with the Threshold and Skeletonization func-
tions in ImageJ, and then converted to skeleton images. The digitized x–y
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coordinates of extremes of the branches in the results represent the axon terminal
distributions and densities in a given area of the section. All branch information
was then transferred into MATLAB (MathWorks, Natick, MA) for further pro-
cessing to generate the regional density heatmaps for each section by custom codes,
with the pure red representing the highest axon density and the pure blue repre-
senting the lowest axon density for each section.
Data quantification. To measure the dPST axon density, we acquired BDA-labeled
images in the field of the ventral horn of the spinal cord using a 20× objective
(Fig. 3d) or 60× oil objective (Fig. 5d). The serial images were imported into ImageJ
and the mean fiber integrated density was calculated. We adjusted the density
values by dividing the area of the selected subregion of the images.
To count close appositions between BDA-labeled dPST axons and CTB-labeled
lumbar MNs, the Z-stack images from cross-sections were acquired using a 60× oil
objective of a confocal fluoview microscope (Olympus, Japan) in the lumbar spinal
cord (L2–L4). We examined all apposed puncta in a 3D-view manner. Only
appositions in all three dimensions were considered as valid candidates to be
counted (indicated as arrowhead in Supplementary Fig. 4e), with the intention of
eliminating other appositions just in one or two dimensions (indicated as arrow in
Supplementary Fig. 4e). We counted all valid appositions of BDA-labeled dPST
axons with 2–4 CTB-labeled MNs within an unbiased virtual courting space in
each section. In each animal, we counted 4–6 sections. The data were expressed as
either appositions per MN per section (Supplementary Fig. 4f) or appositions per
MN per animal (Fig. 5d).
We determine the propriospino-MN synaptic connections by quantification of
the number of colocalized puncta stained for BDA-labeled dPST terminals, CTB-
labeled MN, and a presynaptic marker, synaptophysin. The synapse numbers were
determined by the number of triple appositions in the counting frame by defined
tissue space. As described above, we unbiasedly counted 2–4 MNs in each section
and 4–6 sections per animal. The data were finally expressed as synapses per MN
per section (Fig. 6c).
For analysis of TrkC expression density, images of the ventral horn region were
captured with a 40× objective from transverse sections stained with TrkC
immunohistochemistry. The mean integrated density was measured in Image J
with the same methods described above. To analyze the dPST axon terminals co-
expressing TrkC, we counted the number of double-labeled puncta in TrkC
immunoreactive and BDA-labeled sections in Photoshop. The absolute number of
co-localized puncta in each group was then normalized to dPST fiber density to
allow comparisons of NT-3-induced effect on TrkC expression between groups.
To count the double-infected dPNs, the T4–T8 region of the spinal cord was
dissected out and the serial cryosections were prepared and collected. We counted
and summated the number of GFP-positive cells, when present, in all sections
using Photoshop.
To count the double-infected cells around the B1, B2, and B3 regions of the
caudal brainstem, sagittal and coronal brainstem sections were prepared and all
GFP-positive cells were counted in the raphe nuclei and other neighboring reticular
formation regions. To estimate the number of double-infected serotoninergic
neurons in the brainstem, we counted the number of GFP-positive cells co-
localized with 5-HT-immunoreactive within all regions of interest.
To count the double-infected cells within the A11 region, the total number of
GFP-positive cells in midbrain sections were quantified from bregma −1.5 mm to
−2.5 mm. To assess the double-infected dopaminergic neurons in the A11 region,
we counted the number of GFP-positive cells co-localized with TH-
immunoreactive neurons in the A11 region of all sections.
The EMG responses we collected for statistical quantification in each
experimental group met the following three criteria: (1) the EMG response
contained a peak occurring at the normal latency for the target muscle; (2) such a
peak had to be present in response to at least 4 of the 10 stimuli given; and (3) the
EMG peaks had to be larger than the other peaks from the background. The peak-
to-peak amplitudes and onset latencies of the contralateral EMG responses were
measured in Clampfit (Molecular Devices, USA) and further plotted in R studio
(Open source software).
To assess the density of CST, RST, and monoaminergic fibers in the lumbar
cord, serial immunoreactive sections were traced and reconstructed automatically
with the Imaris software using the FilamentTracer function (BitPlane AG,
Switzerland). The total filament length and the number of branches in the
reconstructions were analyzed to estimate the axon densities in each
experimental group.
To measure the step length and height of the left hindlimb in sham mice and
the mice that received staggered hemisections. The mice were recorded when
walking through a narrow custom-built plexiglass trough (5 cm wide by 40 cm
long) via a high-speed camera. We then used Kinovea (Open source software,
https://www.kinovea.org) to manually trace the motion of all straightforward steps
of left rear paws. Any twist or backward or non-stepping steps were excluded from
the final quantification. Step length was measured by the distance between the
center of subsequent left rear paws; step height was defined by the maximum step
height of left rear paw lifting from the ground.
Statistical analysis. Statistical parameters including the definitions and exact
values of the number of animals, deviations, P values, and the types of the statistical
tests were reported in the figures and corresponding figure legends. Statistical
analysis was carried out using GraphPad Prism software (version 7.00, La Jolla,
California, USA) or R studio. Comparisons between the experimental groups were
performed by one-way ANOVA or two-way ANOVA with Tukey’s post-hoc test.
P < 0.05 was considered statistically significant.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All relevant data as well as computer code supporting the findings of the current study
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